peptual bpc-157 Pure BPC-157: The Body Protection Compound

In stock AOD-9604 is a synthetic peptide fragment supplied as a lyophilised powder in a sealed laboratory vial for analytical and non-clinical research use

In Wales the All Wales Medicines Strategy Group (AWMSG) and in Northern Ireland -the Department of Health, Social Services and Public Safety (DHSSPS) decide how they will be implemented locally

The World Anti-Doping Agency has a committee, composed of experts from around the world who consider input from interested stakeholders and determine the list of Prohibited Substances and Methods

Disclosure of interest: FAM, KG, VR, MK, WNW, KB, PH have nothing to disclose Poster Session II - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.03 - EPIDEMIOLOGY & RISK FACTORS P1005 - ESOC25-1187 PREVALENCE AND OUTCOME OF CEREBRAL MICROBLEEDS IN ANTIPHOSPHOLIPID SYNDROME Jonathan Naftali 1 , Rani Barnea 1 , Ruth Eliahou 1 , Tzippy Shochat 1 , Adi Wilf-Yarkoni 1 , Sivan Bloch 2 , Michael Findler 1 , Avi Leader 3 , Walid Saliba 2 , Eitan Auriel 1 1 Rabin medical center, Tel Aviv University, Petah Tikva, Israel, 2 Carmel medical center, Haifa, Israel, 3 Memorial Sloan Kettering Cancer Center, New-York, United States Background and Aims: Antiphospholipid syndrome (APS) is an acquired autoimmune disease characterized by arterial and venous thrombosis